Abstract

Randomized trials comparing multi-vessel percutaneous coronary intervention to coronary artery bypass grafting (CABG) have demonstrated the long-term superiority of CABG in diabetic patients. Benefits include improved survival, fewer recurrent myocardial infarctions and a lower risk of the need for repeat intervention. The focus of this review article is to review the contemporary management of diabetic patients with multi-vessel coronary artery disease.

Keywords: Percutaneous coronary intervention, Drug eluting stents, Coronary artery bypass grafting, Diabetes mellitus, Coronary artery disease, Revascularization, Survival.